Article Name Global/International
Techsomed Secures FDA 510(k) Clearance for BioTraceIO360 Kidney Ablation Indication
The expanded clearance extends BioTraceIO360 beyond liver applications to kidney procedures, advancing Techsomed’s vision of a multi-organ, AI-driven image-guided therapy platform that standardises minimally invasive cancer care.
23rd September, 2025
Nicklaus Children’s Heart Institute Pioneers Bedside PDA Closures for Fragile Newborns Subheadline
The Institute, led by Dr. Shyam Sathanandam, is transforming neonatal cardiac care by delivering minimally invasive PDA closures directly in the NICU—eliminating transport risks and accelerating recovery for South Florida’s most vulnerable infants.
23rd September, 2025
Apollo Hospitals Launches Apollo Athenaa – Asia’s First Dedicated Cancer Centre for Women in New Delhi
The landmark centre, inaugurated by Delhi’s Chief Minister Smt. Rekha Gupta, sets a global benchmark in women-centric cancer care with a focus on dignity, privacy, and advanced treatment outcomes.
23rd September, 2025
NovaBone Unveils First Fully-Synthetic Bioactive Pre-Contoured Wedge at AOFAS 2025
Breakthrough bioactive glass device offers surgeons a safe, resorbable, and cost-effective alternative to metal implants, engineered to accelerate bone regeneration and streamline surgical workflow.
11th September, 2025
Vivos Files Critical Patent for Hydrogel Electron Beam Sterilisation
The validation was carried out under ISO 11137 by an international medical device accredited organisation
04th September, 2025
Siemens Healthineers and Evident Partner with Klinikum Ludwigshafen to Deliver Fully Digital Pathology Workflow
Alliance integrates Siemens’ digital pathology solutions with Evident’s Pramana platform to modernize diagnostics, unify clinical workflows, and advance AI-driven personalised healthcare in Germany.
04th September, 2025
Abbott’s Navitor™ Wins CE Mark Expansion, Offering Minimally Invasive Valve Replacement to Low- and Intermediate-Risk Patients in Europe
Backed by VANTAGE trial data unveiled at ESC Congress 2025 and published in JACC: Cardiovascular Interventions, Navitor now covers all surgical risk categories—while new ESC/EACTS guidelines also strengthen support for MitraClip™ and TriClip™ in mitral and tricuspid valve disease management.
01st September, 2025
Hesperos’ Human-on-a-Chip® and Digital Twin Platforms Redefine Disease Modeling
CEO Lawrence Florin discusses how human-relevant organ-on-a-chip systems and continuously updated digital twins are improving translational accuracy, reducing reliance on animal testing, and opening new frontiers in precision medicine.
13th August, 2025
Dräger Atlan A350 Series Earns Highest U.S. Cybersecurity Clearance for Medical Devices
Authority to Operate (ATO) certification from the U.S. Department of Defense affirms Dräger’s leadership in safeguarding patient data, delivering a fully ATO-certified anesthesia portfolio trusted by hospitals worldwide.
12th August, 2025
BD Becomes First MedTech Company to Earn Diamond-Level Resiliency Badge Across All HIRC Supply Chain Domains
BD’s Urology and Critical Care and Surgery units achieve top-tier recognition from the Healthcare Industry Resilience Collaborative, affirming its leadership in supply chain transparency, risk mitigation, and operational excellence
06th August, 2025
BD Invests $35M to Expand U.S. Production of PosiFlush™ Prefilled Syringes
The expansion at its Nebraska facility will boost syringe output by hundreds of millions annually, enhancing supply resilience and supporting safe, high-quality patient care across U.S. hospitals.
05th August, 2025
The FDA Is Phasing Out Animal Testing. Our Replacements Must Catch Up Fast.
In April, Health Secretary Robert F. Kennedy Jr. announced plans to dramatically reduce animal testing at U.S. health agencies. The FDA followed with a commitment to phase out animal studies in areas like monoclonal antibody development, favoring in vitro systems and artificial intelligence instead.
04th August, 2025
Demetra Launches Global Spine Division Following Strategic Acquisition of OrthoFundamentals
With the formation of Demetra Spine and recent acquisitions in the US and Europe, Demetra accelerates its mission to revolutionise spinal surgery through infection-reducing, single-use technologies designed for minimally invasive, value-based care.
04th August, 2025
Galaxy Therapeutics Opens New 9,200 Sq. Ft. Facility to Support Global Scale-Up of Brain Aneurysm Solutions
Equipped with ISO Class 7 cleanrooms and expanded R&D capacity, the new site accelerates Galaxy’s path to commercial readiness and global distribution of its breakthrough neurovascular technologies.
31st July, 2025
RIVANNA Secures $9.92M BARDA Funding to Fast-Track AI-Powered Fracture Detection System
With total federal support exceeding $52M, RIVANNA accelerates development of CADe/x — an AI-driven diagnostic tool poised to transform musculoskeletal care through automated ultrasound image analysis and real-time fracture triage.
31st July, 2025
ClariMed Achieves ISO 13485:2016 Certification, Strengthening Global Medical Device Development Capabilities
Milestone underscores ClariMed’s commitment to quality excellence and reinforces its position as a trusted partner in navigating complex global regulatory landscapes
30th July, 2025
TrilliumBiO and T-NeuroDx Partner to Advance Blood-Based Diagnostics for Early Alzheimer’s Detection
Strategic collaboration aims to accelerate validation and commercialisation of non-invasive tests, enabling earlier, more accessible diagnosis of Alzheimer’s disease
30th July, 2025
Quasar Medical Establishes Global Headquarters in Singapore to Drive MedTech Innovation and Global Growth
Strategic relocation from Hong Kong strengthens ties to Asia’s thriving MedTech ecosystem, enhances collaboration with global partners, and supports ambitious expansion plans
30th July, 2025
Medtech Special
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer